Alkermes (ALKS) Short-term Investments (2011 - 2026)
Alkermes (ALKS) reported Short-term Investments of $160.3 million for Q1 2026, down 66.89% year-over-year from $484.2 million in Q1 2025, and down 78.08% quarter-over-quarter from $731.2 million in Q4 2025.
Alkermes (ALKS) Short-term Investments (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 16 years of Short-term Investments data on file, last reported at $160.3 million in Q1 2026.
- Short-term Investments for Q1 2026 came in at $160.3 million, down 66.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $160.3 million (down 66.89% YoY), and the FY2025 annual result was $731.2 million, up 58.78% from the prior year.
- Short-term Investments retreated to $160.3 million in Q1 2026 per ALKS's latest filing, from $731.2 million in the prior quarter.
- Over five years, Short-term Investments peaked at $731.2 million in Q4 2025 and troughed at $160.3 million in Q1 2026.
- A 5-year average of $365.2 million and a median of $324.3 million in 2024 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2024 and 2026: Short-term Investments soared 112.3% in 2024, then tumbled 66.89% in 2026.
- A 5-year view of Short-term Investments shows it stood at $316.0 million in 2022, then grew by 0.01% to $316.0 million in 2023, then surged by 45.72% to $460.5 million in 2024, then surged by 58.78% to $731.2 million in 2025, then plunged by 78.08% to $160.3 million in 2026.
- Business Quant data shows ALKS's Short-term Investments at $160.3 million in Q1 2026, $731.2 million in Q4 2025, and $494.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 160.31 Mn |
| Dec 31, 2025 | 731.21 Mn |
| Sep 30, 2025 | 494.67 Mn |
| Jun 30, 2025 | 494.54 Mn |
| Mar 31, 2025 | 484.21 Mn |
| Dec 31, 2024 | 460.52 Mn |
| Sep 30, 2024 | 512.57 Mn |
| Jun 30, 2024 | 340.97 Mn |
| Mar 31, 2024 | 324.30 Mn |
| Dec 31, 2023 | 316.02 Mn |
| Sep 30, 2023 | 241.44 Mn |
| Jun 30, 2023 | 163.25 Mn |
| Mar 31, 2023 | 279.06 Mn |
| Dec 31, 2022 | 315.99 Mn |
| Sep 30, 2022 | 316.23 Mn |
| Jun 30, 2022 | 326.32 Mn |
| Mar 31, 2022 | 246.32 Mn |
| Dec 31, 2021 | 198.77 Mn |
| Sep 30, 2021 | 249.86 Mn |
| Jun 30, 2021 | 280.00 Mn |